Ongoing research aims to better understand the role of TP53 mutations in cancer development and treatment. Scientists are exploring new therapies targeting TP53-mutant cancers and developing more advanced testing methods to detect these mutations with greater accuracy. The goal is to improve personalized medicine approaches and enhance patient care.
